TrialJournal of diabetes investigation2020

Achieving the composite end-point of glycated hemoglobin <7.0% without weight gain or hypoglycemia with once-weekly dulaglutide in Chinese patients with type 2 diabetes: A post-hoc analysis.

Xinhua Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.